Centene Corporation reported a net loss attributable to the company of USD -1.10 billion for the period. Basic and diluted earnings per common share were both USD -2.24. The weighted average number of common shares outstanding was 491.53 million for basic and diluted calculations. The company noted the impact of state-directed payments, which are recorded as premium revenue and medical costs at close to a 100 percent health benefits ratio. Pass-through payments, defined as non-risk supplemental payments from states that Centene is required to transfer to designated contracted providers, are recorded as premium tax revenue and premium tax expense. Centene reaffirmed its commitment to providing fully integrated, high-quality, and cost-effective services to government-sponsored healthcare programs, emphasizing its local approach with local brands and teams. The company also highlighted that its forward-looking statements, including its 2026 full year guidance, are covered by the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Centene Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: CG82208) on February 06, 2026, and is solely responsible for the information contained therein.